The Small-Cap Value Premium: Real or Dead?

Here's the pitch you'll hear from small-cap value skeptics: Eugene Fama and Kenneth French published their famous three-factor model in 1992, identified the small-cap and value premiums, and the moment the paper hit academic journals, every quant hedge fund on Wall Street piled in — arbitraging the premium out of existence before you even had a chance to benefit from it. It's a compelling story. It's also, at best, half true.

The real story of the small-cap value premium is stranger and more interesting than either the permabull or the skeptic wants to admit. Yes, it has been dead — sometimes for a decade at a stretch. And yes, the long-run historical data shows a premium that is substantial, persistent, and tied to real economic risk. Understanding which of those two realities you're living in right now might be the most important portfolio decision you make this decade.

What Fama and French Actually Found

In 1992, professors Eugene Fama and Kenneth French turned the investing world upside down with a straightforward observation: the Capital Asset Pricing Model (CAPM) — the reigning theory that said market beta explained all returns — was missing something. A lot of somethings, actually.

Their research identified two additional factors that predicted long-run equity returns beyond simple market exposure:

• The Size Premium (SMB — Small Minus Big): Small-cap stocks have historically outperformed large-cap stocks over long periods.
• The Value Premium (HML — High Minus Low): Stocks with high book-to-market ratios ("value" stocks, often cheap or unloved) have outperformed growth stocks over long periods.

Their dataset stretched back to 1927, giving them nearly 70 years of evidence. The findings were robust, peer-reviewed, and replicable. The academic community largely accepted them. And the asset management industry — particularly firms like Dimensional Fund Advisors (DFA), co-founded by David Booth with Fama on its board — built entire investment philosophies around them.

But here's the catch: long-run averages can hide an enormous amount of pain along the way.

The Premium by the Numbers (And Why Starting Date Matters Enormously)

Let's look at the raw data honestly. The small-cap premium is real in the historical record — but it is brutally sensitive to your starting point.

Starting Period	Small-Cap Premium (Annualized)	Notes
Since 1927 (value-weighted)	+2.07%	Full Fama-French dataset; favorable period includes Great Depression recovery
Since 1927 (equally weighted)	+6.69%	Equal-weight boosts micro-caps; not replicable at scale
Since 1970 (any start date)	~0%	Damodaran analysis: premium essentially disappears
Since 1982 (excluding 1975–83 boom)	Negative	The famous small-cap run of the late 1970s dominates older data
Since 2000	Mixed	Early 2000s were excellent for small-cap value; post-2010 was not
Last 20 years	−4 to −4.5%	Small caps have badly lagged large caps annually

NYU professor Aswath Damodaran, one of the most respected valuation researchers alive, ran a sobering analysis: when you start the clock at 1970 or any later date, the small-cap premium drops to approximately zero. The headline figure of 2%+ is essentially carrying the weight of a single extraordinary period — the post-Depression and post-WWII era — on its back.

That's the bear case in a sentence. And it's not wrong.

The Bear Case vs. the Bull Case

Let's steelman both sides, because both are held by serious people with serious data.

The honest answer is that neither camp is entirely right. The premium is real in the data and theoretically grounded in risk compensation — but it comes with multi-year, sometimes multi-decade dry spells that will test any investor's conviction.

Why the Current Setup Is Actually Interesting

Here's what the skeptics who pull out the "arbitraged away" line tend to gloss over: the valuation gap between small and large caps right now is extreme.

From 2010 to 2017, small-cap stocks actually commanded a premium valuation over large caps — investors were willing to pay more in P/E terms for small companies than for the S&P 500. That was arguably the worst time to tilt toward small caps, and the subsequent underperformance made sense: you were overpaying for the premium.

Since 2018, that gap has inverted dramatically. Small caps now trade at historically wide discounts to large caps on a forward price-to-earnings basis. The S&P 500 — driven by the Magnificent Seven — trades at stretched multiples. Meanwhile, the Russell 2000 and small-cap value indexes sit at far more modest valuations. That's not a guarantee of outperformance, but it's the kind of setup that historically precedes it.

Add to that a set of macro tailwinds that are genuinely favorable for smaller companies:

• Declining interest rates: Small caps carry more floating-rate debt and are more sensitive to rate moves. Rate cuts disproportionately benefit them.
• Reshoring and domestic manufacturing: Small and mid-cap industrials are the direct beneficiaries of supply chain repatriation.
• M&A activity: After years of regulatory gridlock, deal flow is picking back up. Small-cap companies are acquisition targets at a premium.
• Tax policy: Domestic-heavy small caps benefit more from corporate tax changes than multinationals.

None of this is guaranteed to play out. But the combination of valuation support and macro tailwinds makes this a more interesting moment for small-cap value than any time since the early 2000s.

The Case for Avantis: Don't Just Buy "Small"

This is where implementation matters as much as theory. Not all small-cap funds are created equal. The original academic small-cap premium was measured using book-to-market ratios and market cap screens — and frankly, a lot of what ends up in traditional small-cap indexes is garbage: zombie companies, money-losers, highly speculative bets.

The smart way to access the small-cap value premium is through factor-aware funds that go beyond simple index construction. And right now, the two best vehicles on the market are both from Avantis Investors:

• AVUV — Avantis U.S. Small Cap Value ETF: Targets profitable U.S. small-cap companies with value characteristics. Not just "cheap" — specifically cheap and profitable. Recent 1-year return: +28.72% with a Sharpe ratio of 1.23, meaning that return came with excellent risk-adjusted efficiency.
• AVSC — Avantis U.S. Small Cap Equity ETF: A broader small-cap fund with factor tilts toward profitability, for investors who want small-cap exposure without a hard value tilt.

What distinguishes Avantis (and DFA, their institutional predecessor) from plain index funds is the profitability screen. Academic research — including the Fama-French five-factor model published in 2015 — identified that profitable small-cap value companies capture a much larger premium than unprofitable ones. AVUV implements this by systematically favoring companies with high book-to-market ratios and high profitability metrics. This doesn't just improve returns — it reduces exposure to the value trap problem where cheap stocks are cheap for good reason.

Both DFA and Avantis small-cap value funds have roughly doubled in value over the last five years — demonstrating that when the premium shows up, it shows up emphatically.

"The premium doesn't arrive on a schedule. It arrives all at once, when least expected, after you've had about seven years of quietly wondering if you made a mistake."

How This Fits Into a VTI & Chill Portfolio

At VTI & Chill, we're not anti-tilt. We're anti-complexity for its own sake. The small-cap value premium is one of the few documented, theoretically grounded, academically supported reasons to deviate from a pure total market fund — so it earns its place in our Better and Best portfolio tiers.

Here's how the tiers approach it:

• Good (VTI Only): Pure total market. Zero factor tilts. Own the whole market at the lowest possible cost. You capture some small-cap exposure naturally — VTI holds about 7% small-cap — but it's market-weighted, not intentionally tilted. This is still an excellent portfolio for most people.
• Better (VTI + AVUV): Add a dedicated small-cap value tilt via AVUV at 10–20% of your equity allocation. This intentionally overweights profitable small-cap value companies without abandoning the core total market exposure. Historically, this improves risk-adjusted returns over 30+ year periods — with the understanding that you will experience 5–10 year stretches where AVUV trails VTI.
• Best (VTI + AVUV + AVSC + International): Full factor tilt across domestic and international equities. Add AVSC for broader small-cap exposure, and AVDV or AVDS for international small-cap value. This is the Merriman-inspired maximum diversification approach — every documented equity premium, captured efficiently, at low cost. Requires the most conviction and the most patience.

The key phrase in all of this: patience. Paul Merriman has spent decades documenting how small-cap value tilts improve outcomes across every rolling 40-year historical period in U.S. data. But even he acknowledges the path is not smooth. His counterpart in the debate, Karsten Jeske (Big ERN), makes a fair point that for investors near retirement, the sequence-of-returns risk from small-cap volatility deserves careful consideration. The tilt makes most sense when you have a long runway — ideally 20+ years — to survive the dry spells.